Boston Partners
- SEC CIK
- 0001386060
- Latest filing
- Aug 4, 2026
AZN holding history
AstraZeneca PLC in every 13F filed by Boston Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AZN overviewAll 13F holders of AZNFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,177,627
- Value
- $597.4M
- % of portfolio
- 0.5%
- Quarters held
- 13
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,177,627 | $597.4M | 0.5% | +1,083,731+51.8% | Added | Holders |
| Q1 2026 | 2,093,896 | $413.4M | 0.4% | −21,000−1.0% | ReducedConverted for a 1-for-2 split | Holders |
| Q4 2025 | 4,229,792 | $389.4M | 0.4% | −1,017,657−19.4% | Reduced | Holders |
| Q3 2025 | 5,247,449 | $405.0M | 0.4% | +257,525+5.2% | Added | Holders |
| Q2 2025 | 4,989,924 | $349.9M | 0.4% | −46,721−0.9% | Reduced | Holders |
| Q1 2025 | 5,036,645 | $368.7M | 0.4% | +1,329,166+35.9% | Added | Holders |
| Q4 2024 | 3,707,479 | $243.4M | 0.3% | +3,670,719+9,985.6% | Added | Holders |
| Q3 2024 | 36,760 | $2.86M | <0.1% | +32,814+831.6% | Added | Holders |
| Q2 2024 | 3,946 | $308.7K | <0.1% | −544−12.1% | Reduced | Holders |
| Q1 2024 | 4,490 | $308.6K | <0.1% | +4,490 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −3,107−100.0% | Sold out | Holders |
| Q3 2023 | 3,107 | $210.4K | <0.1% | +57+1.9% | Added | Holders |
| Q2 2023 | 3,050 | $218.3K | <0.1% | −585−16.1% | Reduced | Holders |
| Q1 2023 | 3,635 | $252.3K | <0.1% | +3,635 | New | Holders |